MSB 0.91% $1.11 mesoblast limited

sce recommendation

  1. 54 Posts.
    Renewed recommendation from Southern Cross Equities biotech analyst and their head of institutional dealing. Charlie Aitken is well followed and usually a good price increase in the days following a recommendation in his daily newsletter. Watching it go up!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.